Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure.
about
Relevance of the Carotid Body Chemoreflex in the Progression of Heart FailureRole of the carotid body in the pathophysiology of heart failureCarotid body chemoreceptors, sympathetic neural activation, and cardiometabolic diseaseHypoxia-induced ventilatory responses in conscious mice: gender differences in ventilatory roll-off and facilitationAutonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease.Ventilatory responses to chemoreflex stimulation are not enhanced by angiotensin II in healthy humansLeft atrial size, chemosensitivity, and central sleep apnea in heart failureAge-related reflex responses from peripheral and central chemoreceptors in healthy men.Modulation of ventilatory reflex control by cardiac resynchronization therapy.Prediction of the Chemoreflex Gain by Common Clinical Variables in Heart Failure.Chemosensitivity, Cardiovascular Risk, and the Ventilatory Response to Exercise in COPD.Effect of exercise training on ventilatory efficiency in patients with heart disease: a review.Recruitment Maneuver in Elderly Patients with Different Peripheral Chemoreflex Sensitivity during Major Abdominal Surgery.Chemohypersensitivity and autonomic modulation of venous capacitance in the pathophysiology of acute decompensated heart failure.Pathophysiology and potential clinical applications for testing of peripheral chemosensitivity in heart failure.Heart failure and sleep disorders.Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.Neurohormonal activation in heart failure with reduced ejection fraction.Central chemoreflex activation induces sympatho-excitation without altering static or dynamic baroreflex function in normal rats.The Influence of Age on Interaction between Breath-Holding Test and Single-Breath Carbon Dioxide Test.Cardiopulmonary exercise test predicts sustained ventricular arrhythmias in chronic heart failure.Ventilatory oscillations at exercise: effects of hyperoxia, hypercapnia, and acetazolamide.Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment?Elevated serum bicarbonate concentration in chronic kidney disease: a call to find the cause.The association between leukocyte telomere lengths and sleep instability based on cardiopulmonary coupling analysis.Resonance as the Mechanism of Daytime Periodic Breathing in Patients with Heart Failure.Evaluation of Breath-Holding Test in Assessment of Peripheral Chemoreflex Sensitivity in Patients with Chronic Heart Failure.Carotid body modulation in systolic heart failure from the clinical perspective.Periodic Breathing during Incremental Exercise.Treatment of Cheyne-Stokes respiration reduces arrhythmic events in chronic heart failure.Effects of the recombinant form of the natural human B-type natriuretic peptide and levosimendan on pulmonary hyperventilation and chemosensivity in heart failure.Revisiting the Physiological Effects of Exercise Training on Autonomic Regulation and Chemoreflex Control in Heart Failure: Does Ejection Fraction Matter?Treating chemoreflex in heart failure: modulation or demolition?Analysis of generic coupling between EEG activity and PETCO2 in free breathing and breath-hold tasks using Maximal Information Coefficient (MIC).
P2860
Q26771307-EA16B8EC-81BB-43F3-898C-DDDACE81D94FQ26853502-3C83AA2F-3F3E-48BB-B4F2-2D117F04D73AQ28076487-82175078-1164-4BCD-BAE4-8527C427EF34Q30415118-2F350A09-89EF-408E-91FA-427F6CECFBDBQ31165571-F63C33F0-0D81-4BCF-A0DE-61B831BAA5FAQ33758241-1AC76123-C6A8-47C9-975B-232CB3EE1960Q33829673-60322878-3129-4DFF-9FC2-D7B25CABBA94Q34635089-5792A140-7B6C-4A5F-81DA-F43906524242Q35572255-8FB9F8F6-C9CC-4A37-823F-CB6F5A1DF0CEQ35995599-D42AA846-94F0-470B-9045-AF1ED23EEE39Q36063861-3013808B-B7FA-40A1-BC30-EB74E05BE499Q37032940-E53B6F7B-B634-45C7-95E4-372777E00AE7Q37533356-F457EC81-49E8-4397-8C5A-C914ED5833DDQ38090531-A840CAA8-3BE8-4C0A-905A-15856A64AF25Q38184969-9795835F-2292-43E0-AF58-80D579AD263BQ38833163-260BCA34-9D88-4244-B828-1CFA8A46AAC1Q38970479-1C773FF7-4063-4466-8A33-F98AEA0569FDQ38973209-5DDCFFF1-FDDA-4085-B07C-6D5461A56A2DQ41037605-18DBAFE2-5308-454D-85DA-5D67F3C329F5Q41907439-EE3064C2-874C-4062-A367-3BEB7EF77596Q41994619-DC388F6E-9E9C-4734-8FE4-A86605B4D11AQ42120765-055D33B6-E0DC-49DF-9656-0A106F9E0505Q43115758-546579B3-FDD5-4C0C-99A9-BBA131630888Q43242606-9B0E101F-DF1B-48F9-8A0E-7563A855975CQ44360690-F17B1766-3D33-4977-B578-ACCD583F8161Q46326097-493968E1-83BD-4E51-AF40-9C28063B2A21Q47641635-1E213EF1-051A-47EF-8765-2E29B62C34D5Q47876141-F00C554E-7CAF-492F-9EC9-91B4512C4133Q47909886-8A38EBDB-D442-40C5-B1EA-3617EAC58776Q48166545-0F927915-C6BF-4C1A-92B8-65598EF8B8B8Q48922773-95E7B251-1759-4206-AD98-8DA388376118Q49789531-8F42B79E-33A1-4287-B2CD-30CD4305EE90Q51729620-A82D064B-1555-426E-AA23-672AA03FA383Q53434129-50B02014-FF54-49C1-9963-F4420F07DAFE
P2860
Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Combined increased chemosensit ...... ognosticator in heart failure.
@en
Combined increased chemosensit ...... ognosticator in heart failure.
@nl
type
label
Combined increased chemosensit ...... ognosticator in heart failure.
@en
Combined increased chemosensit ...... ognosticator in heart failure.
@nl
prefLabel
Combined increased chemosensit ...... ognosticator in heart failure.
@en
Combined increased chemosensit ...... ognosticator in heart failure.
@nl
P2093
P921
P1476
Combined increased chemosensit ...... rognosticator in heart failure
@en
P2093
Antonio Barsotti
Darrel P Francis
Francesca Bramanti
Giovanni Iudice
Massimo Piepoli
Michele Emdin
P304
P356
10.1016/J.JACC.2009.02.030
P407
P577
2009-05-01T00:00:00Z